Concepedia
1
Publications
28
Citations
H-Index
2015
Active since
Affiliations
Novartis (Switzerland)(Current)
William Malcolm is an author at Novartis (Switzerland).
Publications per year
2015–2015
Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective
Stéphane A. Régnier, William Malcolm, Jennifer Haig et al. · ClinicoEconomics and Outcomes Research · 2015 · 28 citations · Full text
Rows per page
1–1 of 1